Concepedia

Tina Rubic-Schneider

TR

Statistics

Publications

10

Citations

834

H-Index

10

Active since

2016

Affiliations

Novartis Institutes for BioMedical Research(Current)

Novartis (Switzerland)

Novartis (United States)

Novartis (China)

Tina Rubic-Schneider is an author at Novartis Institutes for BioMedical Research specializing in immunology, life sciences, and immunopathology.

ORCID

Publications per year

2016–2023

10

Publications

10

GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis

Amanda Littlewood‐Evans, Sophie Sarret, Verena Apfel et al. · The Journal of Experimental Medicine · 2016 · 494 citations · Full text

, , +17

Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations

Christine Guntermann, Alessandro Piaia, Marie-Laure Hamel et al. · JCI Insight · 2017 · 58 citations · Full text

, , +15

Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers

Carl Uli Bialucha, Scott D. Collins, Xiao Li et al. · Cancer Discovery · 2017 · 55 citations · Full text

, , +15

GPR91 deficiency exacerbates allergic contact dermatitis while reducing arthritic disease in mice

Tina Rubic-Schneider, Nicole Carballido‐Perrig, Camille Regairaz et al. · Allergy · 2016 · 41 citations · Full text

, , +17

Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology

Kea Martin, Ursula Junker, Elaine Tritto et al. · Frontiers in Immunology · 2020 · 39 citations · Full text

, , +17

1–5 of 10